Release Date ![[down]](http://us.i1.yimg.com/us.yimg.com/i/fi/down.gif) |
Contributor |
Author |
Title |
Pages |
Price |
StarMine Author Rating | More Info |
| EPS Accuracy * |
Portfolio Return ** |
| 5-Nov-09 | First Global | Kavita Thomas, Devina Mehra | First Global reiterates MarketPerform on GlaxoSmithKline Plc. | 12 | $25 | | | View Abstract |
| 24-Oct-09 | First Global | Kavita Thomas, Devina Mehra | First Global reiterates ST MarketPerform on Eli Lilly & Co. | 13 | $50 | | | View Abstract |
| 23-Oct-09 | First Global | Kavita Thomas, Devina Mehra | First Global reiterates MarketPerform on Merck & Co. (MRK) | 12 | $25 | | | View Abstract |
| 22-Oct-09 | First Global | Kavita Thomas, Devina Mehra | First Global reiterates Sector Outperform on Amgen Inc. | 12 | $25 | | | View Abstract |
| 22-Oct-09 | First Global | Kavita Thomas, Devina Mehra | First Global reiterates Moderate Outperform on Pfizer Inc | 12 | $25 | | | View Abstract |
| 21-Oct-09 | First Global | Kavita Thomas, Devina Mehra | First Global rates Biogen Idec as ST MarketPerform | 13 | $50 | | | View Abstract |
| 21-Oct-09 | First Global | Kavita Thomas, Devina Mehra | First Global reiterates Moderate Outperform on Gilead Sciences | 13 | $50 | | | View Abstract |
| 15-Oct-09 | First Global | Kavita Thomas, Devina Mehra | First Global reiterates ST MarketPerform on Abbott Inc. | 13 | $50 | | | View Abstract |
| 14-Oct-09 | First Global | Kavita Thomas, Devina Mehra | First Global reiterates Moderate Outperform on Johnson & Johnson Inc. | 15 | $50 | | | View Abstract |
| 10-Oct-09 | First Global | Kavita Thomas, Devina Mehra | First Global rates Global Pharma sector at MarketPerform | 27 | $75 | | | View Abstract |